 Science Recorder |
New drug could reduce asthma attacks by 87 percent
Fox News An experimental drug being developed by Regeneron Pharmaceuticals Inc. and Sanofi SA showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians cautioned that … UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer New Asthma Drug Generates Excitement For Patients — And Its Maker Experimental drug touted as potential game changer for asthma sufferers |
View full post on asthma – Google News